New capabilities help pharmaceutical and other companies make faster and more effective shipping decisions
Chicago-based project44, a supply chain visibility and logistics service, announced a series of new capabilities offering enhanced collaboration, automation and predictive insights to help shippers drive performance, productivity and customer experience.
In the pharmaceutical and biotech sectors the company provides a range of temperature control services, predictive tracking, secure data flow, collaboration, rapid carrier onboarding and accelerated ROI, according to the company.
Transportation and shipping types served by project44 include air, rail, ocean, truckload, less-than-truckload, final-mile and other modes in more than 120 countries.
"With increasing demands for agility, the world's leading brands are looking for a new level of real-time collaboration, automation and predictive insights,” said Jett McCandless, founder and CEO of project44. “Our new capabilities can help them make faster, more effective decisions and, as a result, build more resilient supply chains."
The newly launched capabilities include:
Life sciences companies using project44 services include AbbVie, Bayer, the Alcon unit of Novartis, pharmacy chain Walgreens and medical equipment company ResMed, according to the project44 website.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.